Michael Winlo
Chief Executive Officer at EMYRIA LIMITED
Net worth: 18 698 $ as of 30/03/2024
Profile
Michael Winlo is the founder of Cerulean Medical Pty Ltd.
(founded in 2007).
He is currently the Chief Executive Officer, Director & MD at Emyria Ltd., a Non-Executive Director at dorsaVi Ltd.
(starting in 2023), a Director at Linear Clinical Research Ltd., and a Non-Executive Director at Nanoveu Ltd.
(starting in 2023).
Dr. Winlo has an MBA from Stanford University and an undergraduate degree from The University of Western Australia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EMYRIA LTD
0.13% | 07/08/2023 | 485,794 ( 0.13% ) | 18 698 $ | 30/03/2024 |
Michael Winlo active positions
| Companies | Position | Start |
|---|---|---|
| EMYRIA LIMITED | Chief Executive Officer | 02/10/2019 |
| NANOVEU LIMITED | Director/Board Member | 27/03/2023 |
| DORSAVI LTD | Director/Board Member | 24/10/2023 |
| Linear Clinical Research Ltd. | Director/Board Member | 30/09/2019 |
Former positions of Michael Winlo
| Companies | Position | End |
|---|---|---|
| Cerulean Medical Pty Ltd. | Founder | - |
Training of Michael Winlo
| Stanford University | Masters Business Admin |
| The University of Western Australia Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| DORSAVI LTD | Electronic Technology |
| NANOVEU LIMITED | Electronic Technology |
| EMYRIA LIMITED | Technology Services |
| Private companies | 2 |
|---|---|
| Linear Clinical Research Ltd. | |
| Cerulean Medical Pty Ltd. | Health Technology |
- Stock Market
- Insiders
- Michael Winlo
